[5.6] vaccinations Flashcards
1
Q
what are the 4 types of immunity?
A
- active natural immunity
- active artificial immunity
- passive natural immunity
- passive artificial immunity
(active = long term, passive = short term)
2
Q
what is active immunity?
A
- primary immune response occurs due to exposure to specific antigen
- so memory B + T lymphocytes are produced
- so secondary immune response is possible if re-exposed to the same strain with the same specific antigen
3
Q
what is an example of active natural / active artificial immunity?
A
- natural = due to infection leading to exposure to specific antigen
- artificial = due to vaccination leading to exposure to a specific antigen
4
Q
what is passive immunity?
A
- no exposure to antigen
- so, no primary response so no memory cells made
- so, no secondary response is possible
- therefore, you have to get antibodies from elsewhere
- quicker than active immunity
5
Q
what is an example passive natural / passive artificial immunity?
A
- natural = antibodies directly supplied during pregnancy from mother to baby via placenta and through breast milk for early protection
- artificial = direct injection of antibodies into the bloodstream as an emergency precaution if possibly exposed to a dangerous pathogen eg. rabies virus
6
Q
what are some features of an effective vaccination programme?
A
- economically available in sufficient quantities to immunise most the vulnerable population
- few side effects
> unpleasant side effects may discourage individuals in the population from being vaccinated - means of producing, storing and transporting the vaccine must be available
> this involves technologically advanced equipment, hygienic conditions, and refrigerated transport - means of administering the vaccine properly at the appropriate time
> this involves training staff with appropriate skills at different centres throughout the population - must be possible to vaccinate the vast majority of the vulnerable population to produce herd immunity
7
Q
what is herd immunity?
A
- when a sufficiently large proportion of the population has been vaccinated so it is difficult for a pathogen to spread within that population
- the concept is based on the idea that pathogens are passed from individual to individual when in close contact
- where the vast majority of the population is immune, it is highly improbable that a susceptible individual will come in contact with an infected person
- in this way those individuals who are not immune to the disease are nevertheless protected
8
Q
why is herd immunity important?
A
- it is never possible to vaccinate everyone in a large population
> babies and very young are not vaccinated as their immune system is not yet fully functional - could also be dangerous to vaccinate those who are ill or have a compromised immune system
9
Q
why may vaccinations not eliminate a disease?
A
- vaccination fails to induce immunity in certain individuals eg. those with defective immune systems
- individuals may develop disease immediately after vaccination but before their immunity levels are high enough to prevent it. these individuals may harbour the pathogen and reinfect others
- pathogen may mutate frequently, so its antigens change suddenly. vaccine becomes ineffective, as immune system does not produce the antibodies to destroy the pathogen (concept of antigenic variability)
- too many varieties of a particular pathogen so it is impossible to develop a vaccine that is effective against them all
- some pathogens ‘hide’ from the body’s immune system by either concealing themselves inside cells or living in places out of reach eg. intestines
- individuals may have objections to vaccination for religious, ethical or medical reasons
10
Q
what are some ethical considerations of vaccines?
A
- development of vaccines will involve animal testing, and the inevitable death of some animals: to what extent is this acceptable and why?
- which animals would it be acceptable to use for testing and why?
- once a vaccine has reached the human trial stage, what factors should be considered to decide who the vaccines should be tested on?
- should people be paid for being part of a vaccine trial?
- what severity of side effects from a vaccine can be considered acceptable?
- once a vaccine programme has successfully reduced the spread of a disease, should money continue to be spent on the programme, or on other health concerns?
- is the use of experimental (ie. not fully trialled) vaccines acceptable, and if so, in what circumstances?